Richard Faull
#40,920
Most Influential Person Now
New Zealand neuroscientist
Richard Faull's AcademicInfluence.com Rankings
Richard Faullbiology Degrees
Biology
#4039
World Rank
#6085
Historical Rank
Neuroscience
#568
World Rank
#593
Historical Rank
Download Badge
Biology
Richard Faull's Degrees
- PhD Neuroscience University of Auckland
- Bachelors Anatomy University of New Zealand
Why Is Richard Faull Influential?
(Suggest an Edit or Addition)According to Wikipedia, Sir Richard Lewis Maxwell Faull is a New Zealand neuroscientist and academic who specialises in human neurodegenerative diseases. He is a professor of anatomy and director of the Centre for Brain Research at the University of Auckland.
Richard Faull's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The use of c-fos as a metabolic marker in neuronal pathway tracing (1989) (1394)
- The organization of the projection from the cerebral cortex to the striatum in the rat (1989) (1364)
- Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors (2019) (897)
- Efferent connections and nigral afferents of the nucleus accumbens septi in the rat (1978) (892)
- AXOR12, a Novel Human G Protein-coupled Receptor, Activated by the Peptide KiSS-1* (2001) (867)
- Human Neuroblasts Migrate to the Olfactory Bulb via a Lateral Ventricular Extension (2007) (825)
- Regional and cellular gene expression changes in human Huntington's disease brain. (2006) (746)
- Brain-derived neurotrophic factor is reduced in Alzheimer's disease. (1997) (533)
- Localization of LRRK2 to membranous and vesicular structures in mammalian brain (2006) (530)
- Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain (2003) (524)
- Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease (2013) (395)
- In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes (1995) (377)
- Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. (2007) (322)
- Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases (2000) (309)
- The cells of origin of nigrotectal, nigrothalamic and nigrostriatal projections in the rat (1978) (300)
- Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain (2014) (284)
- Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration (2012) (230)
- Loss of cannabinoid receptors in the substantia nigra in huntington's disease (1993) (214)
- The Neuropathology of Huntington's Disease. (2015) (204)
- Alzheimer's disease: Changes in hippocampal N-methyl-d-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors—an autoradiographic study (1990) (200)
- Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease (2004) (197)
- DNA instability in postmitotic neurons (2008) (192)
- Long-term potentiation and the induction of c-fos mRNA and proteins in the dentate gyrus of unanesthetized rats (1989) (189)
- An ovine transgenic Huntington's disease model. (2010) (186)
- Proteomic analysis of the brain in Alzheimer’s disease: Molecular phenotype of a complex disease process (2001) (178)
- Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. (2010) (177)
- Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain (2011) (175)
- Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease (1997) (174)
- Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22 (2002) (173)
- Neuroprotective effects of adenosine. (1988) (172)
- Localization of Parkinson’s disease-associated LRRK2 in normal and pathological human brain (2007) (167)
- The effect of neurodegenerative diseases on the subventricular zone (2007) (165)
- Ascending projections of the substantia nigra in the rat , (1968) (165)
- Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels (2016) (164)
- Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra. (1969) (161)
- Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellularin situ hybridization study (1996) (159)
- 3‐Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration (1998) (158)
- Immunohistochemical staining of post-mortem adult human brain sections (2006) (154)
- Distinct neuroinflammatory profile in post-mortem human Huntington's disease (2009) (150)
- Immediate-early genes, kindling and long-term potentiation (1989) (150)
- Comparative distribution of voltage-gated sodium channel proteins in human brain. (2001) (148)
- The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients (2017) (145)
- A comparative study of the neurons of origin of the spinocerebellar afferents in the rat, Cat and squirrel monkey based on the retrograde transport of horseradish peroxidase (1978) (145)
- Regional and cellular distribution of the P2Y1 purinergic receptor in the human brain: Striking neuronal localisation (2000) (144)
- Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain (2004) (143)
- Altered arginine metabolism in Alzheimer's disease brains (2014) (141)
- Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus (1997) (140)
- Excitatory amino acid receptors in the human cerebral cortex: A quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine,l-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites (1989) (139)
- Abnormalities in the synaptic vesicle fusion machinery in Huntington’s disease (2001) (139)
- Induction of c-fos mRNA and protein in neurons and glia after traumatic brain injury: Pharmacological characterization (1990) (138)
- The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington’s disease human brain (2005) (133)
- Markers for human brain pericytes and smooth muscle cells (2018) (133)
- Cholinergic neuronal defect without cell loss in Huntington's disease. (2006) (133)
- Delayed onset of huntington′s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors (2004) (132)
- Striosomes and mood dysfunction in Huntington's disease. (2007) (131)
- Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men (2013) (128)
- Glutamate Uptake is Reduced in Prefrontal Cortex in Huntington’s Disease (2008) (126)
- TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function (2016) (124)
- A role for human brain pericytes in neuroinflammation (2014) (124)
- Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice (2009) (120)
- Loss of A1 adenosine receptors in human temporal lobe epilepsy (1996) (119)
- Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia (2000) (117)
- Neurogenesis and progenitor cells in the adult human brain: A comparison between hippocampal and subventricular progenitor proliferation (2012) (117)
- Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease (2017) (116)
- Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease (2007) (115)
- Cleavage at the 586 Amino Acid Caspase-6 Site in Mutant huntingtin Influences Caspase-6 Activation In Vivo (2010) (114)
- Distribution of voltage‐gated sodium channel α‐subunit and β‐subunit mRNAs in human hippocampal formation, cortex, and cerebellum (2000) (114)
- Trk receptor alterations in Alzheimer's disease. (1996) (112)
- ABC efflux transporters in brain vasculature of Alzheimer's subjects (2010) (112)
- Regional protein expression in human Alzheimer’s brain correlates with disease severity (2018) (112)
- GABA, GABA receptors and benzodiazepine receptors in the human spinal cord: An autoradiographic and immunohistochemical study at the light and electron microscopic levels (1990) (109)
- Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson’s disease (2008) (107)
- Insulin-Like Growth Factor-1 Reduces Postischemic White Matter Injury in Fetal Sheep (2001) (106)
- Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It? (2019) (106)
- Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington’s disease (2014) (105)
- The distribution of calbindin, calretinin and parvalbumin immunoreactivity in the human thalamus (2000) (105)
- Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease (2009) (105)
- Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder (2016) (104)
- Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum (1998) (102)
- The nigrotectal projection and tectospinal neurons in the rat. a light and electron microscopic study demonstrating a monosynaptic nigral input to identified tectospinal neurons (1988) (102)
- Doublecortin expression in the normal and epileptic adult human brain (2008) (100)
- Increased acetyl and total histone levels in post-mortem Alzheimer's disease brain (2015) (99)
- Response to Comment on "Human Neuroblasts Migrate to the Olfactory Bulb via a Lateral Ventricular Extension" (2007) (97)
- N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats (2000) (97)
- α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson’s disease patients (2017) (97)
- The cellular composition and morphological organization of the rostral migratory stream in the adult human brain (2009) (96)
- Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. (2000) (95)
- Effects of hypoxia-ischemia and seizures on neuronal and glial-like c-fos protein levels in the infant rat (1990) (95)
- Autoradiographic localisation of NMDA, quisqualate and kainic acid receptors in human spinal cord (1990) (95)
- GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. (2003) (93)
- The transcription factor PU.1 is critical for viability and function of human brain microglia (2013) (93)
- Regional and cellular localisation of GABAA receptor subunits in the human basal ganglia: An autoradiographic and immunohistochemical study (1999) (93)
- Neurogenesis in humans (2011) (92)
- The Role of Microglia and Astrocytes in Huntington’s Disease (2019) (92)
- Expression of Fos, Jun, and Krox Family Proteins in Alzheimer's Disease (1997) (90)
- Benzodiazepine receptors in the human spinal cord: A detailed anatomical and pharmacological study (1986) (90)
- Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease (1996) (89)
- Comparative cellular distribution of GABAA and GABAB receptors in the human basal ganglia: Immunohistochemical colocalization of the α1 subunit of the GABAA receptor, and the GABABR1 and GABABR2 receptor subunits (2004) (89)
- Amyloid-like inclusions in Huntington’s disease (2000) (89)
- The GABAergic system as a therapeutic target for Alzheimer's disease (2018) (88)
- TATA-binding protein in neurodegenerative disease (2005) (87)
- Cannabinoid (CB1), GABAA and GABAB receptor subunit changes in the globus pallidus in Huntington's disease (2009) (86)
- XCE, a new member of the endothelin-converting enzyme and neutral endopeptidase family, is preferentially expressed in the CNS. (1999) (85)
- Loss of SNAP‐25 and rabphilin 3a in sensory‐motor cortex in Huntington’s disease (2007) (84)
- M-CSF increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia (2013) (84)
- Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia (2000) (84)
- PROGENITOR CELLS AND ADULT NEUROGENESIS IN NEURODEGENERATIVE DISEASES AND INJURIES OF THE BASAL GANGLIA (2007) (83)
- PU.1 regulates Alzheimer’s disease-associated genes in primary human microglia (2018) (80)
- Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease. (2016) (79)
- Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia (2013) (79)
- GABA(B) receptor heterodimer-component localisation in human brain. (2000) (77)
- The distribution of GABAA-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid-lesioned rat. (1993) (76)
- Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus (2001) (76)
- A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals (1999) (76)
- Unique and shared inflammatory profiles of human brain endothelia and pericytes (2018) (75)
- [3H]Glycine binding sites, NMDA and PCP receptors have similar distributions in the human hippocampus: an autoradiographic study (1989) (75)
- Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8. (1999) (72)
- Sigma receptors are highly concentrated in the rat pineal gland (1990) (70)
- Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in huntington's disease (1993) (69)
- Muscarinic cholinergic receptors in the human spinal cord: differential localization of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding sites (1985) (69)
- Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice (2010) (69)
- Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains. (1996) (68)
- Isolation of highly enriched primary human microglia for functional studies (2016) (68)
- Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease (2018) (67)
- A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain (2005) (66)
- GABAA receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus (2018) (64)
- Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer’s disease: metabolic basis for dementia (2016) (64)
- Insoluble TATA-binding protein accumulation in Huntington's disease cortex. (2002) (64)
- The visual cortico-striato-nigral pathway in the rat (1986) (63)
- The distribution of neurotensin receptors and acetylcholinesterase in the human caudate nucleus: evidence for the existence of a third neurochemical compartment (1989) (61)
- Early and progressive circadian abnormalities in Huntington's disease sheep are unmasked by social environment. (2014) (61)
- Characterization of [3H]Quisqualate Binding to Recombinant Rat Metabotropic Glutamate 1a and 5a Receptors and to Rat and Human Brain Sections (2000) (60)
- Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro. (1999) (60)
- Localization of Glycine Receptors in the Human Forebrain, Brainstem, and Cervical Spinal Cord: An Immunohistochemical Review (2009) (59)
- Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus. (1997) (59)
- Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains (2006) (59)
- Impaired expression of GABA transporters in the human Alzheimer’s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus (2017) (59)
- Brain urea increase is an early Huntington’s disease pathogenic event observed in a prodromal transgenic sheep model and HD cases (2017) (59)
- The collection and processing of human brain tissue for research (2008) (58)
- Immunohistochemical localisation of the creatine transporter in the rat brain (2009) (57)
- Impact of perinatal asphyxia on the GABAergic and locomotor system (2003) (57)
- Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia. (2017) (57)
- Cellular composition of human glial cultures from adult biopsy brain tissue (2007) (56)
- Distribution of voltage-gated sodium channel alpha-subunit and beta-subunit mRNAs in human hippocampal formation, cortex, and cerebellum. (2000) (56)
- Multiple benzodiazepine receptors in the human basal ganglia: A detailed pharmacological and anatomical study (1988) (56)
- Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease. (2014) (55)
- Symptom heterogeneity in Huntington's disease correlates with neuronal degeneration in the cerebral cortex (2016) (54)
- Adult Human Brain Neural Progenitor Cells (NPCs) and Fibroblast-Like Cells Have Similar Properties In Vitro but Only NPCs Differentiate into Neurons (2012) (54)
- Cortical interneuron loss and symptom heterogeneity in Huntington disease (2014) (54)
- Apoptosis, Neurotrophic Factors and Neurodegeneration (1997) (54)
- The regional, cellular and subcellular localization of GABAA/benzodiazepine receptors in the substantia nigra of the rat (1992) (53)
- Selective neuroprotective effects with insulin-like growth factor-1 in phenotypic striatal neurons following ischemic brain injury in fetal sheep (1999) (52)
- Cell-Type-Specific Gene Expression Profiling in Adult Mouse Brain Reveals Normal and Disease-State Signatures. (2019) (51)
- Identification of elevated urea as a severe, ubiquitous metabolic defect in the brain of patients with Huntington's disease. (2015) (51)
- Opiate receptors in the human spinal cord: A detailed anatomical study comparing the autoradiographic localization of [3H]diprenorphine binding sites with the laminar pattern of substance P, myelin and nissl staining (1987) (50)
- The IGF-I Amino-Terminal Tripeptide Glycine-Proline-Glutamate (GPE) Is Neuroprotective to Striatum in the Quinolinic Acid Lesion Animal Model of Huntington's Disease (1999) (50)
- Valproic acid induces microglial dysfunction, not apoptosis, in human glial cultures (2011) (48)
- A ventral glomerular deficit in Parkinson’s disease revealed by whole olfactory bulb reconstruction (2017) (47)
- Prolonged and selective induction of Fos-related antigen(s) in striatal neurons after 6-hydroxydopamine lesions of the rat substantia nigra pars compacta. (1991) (47)
- N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats (2004) (47)
- Assessing RNA quality in postmortem human brain tissue. (2008) (46)
- Distribution of PSA-NCAM in normal, Alzheimer’s and Parkinson’s disease human brain (2016) (45)
- Increased Precursor Cell Proliferation after Deep Brain Stimulation for Parkinson's Disease: A Human Study (2014) (45)
- String Vessel Formation is Increased in the Brain of Parkinson Disease. (2015) (45)
- Sex- and age-related changes in GABA signaling components in the human cortex (2019) (45)
- Further molecular characterisation of the OVT73 transgenic sheep model of Huntington's disease identifies cortical aggregates. (2013) (44)
- Metabolic disruption identified in the Huntington’s disease transgenic sheep model (2016) (43)
- An anti-inflammatory role for C/EBPδ in human brain pericytes (2015) (43)
- Glycine receptors in the striatum, globus pallidus, and substantia nigra of the human brain: An immunohistochemical study (2007) (43)
- GABAA receptors in the primate basal ganglia: An autoradiographic and a light and electron microscopic immunohistochemical study of the α1 and β2,3 subunits in the baboon brain (1998) (43)
- Dissociated Expression of Mitochondrial and Cytosolic Creatine Kinases in the Human Brain: A New Perspective on the Role of Creatine in Brain Energy Metabolism (2013) (42)
- Sox-2 is expressed by glial and progenitor cells and Pax-6 is expressed by neuroblasts in the human subventricular zone (2007) (42)
- LocaliZation of metabotropic glutamate receptor type 2 in the human brain (1999) (42)
- GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease (1995) (41)
- Extracellular signal-regulated kinase involvement in human astrocyte migration (2007) (41)
- Differential Changes in Postsynaptic Density Proteins in Postmortem Huntington's Disease and Parkinson's Disease Human Brains (2014) (40)
- Cultured pericytes from human brain show phenotypic and functional differences associated with differential CD90 expression (2016) (40)
- Differential effects of acute dopaminergic D1 and D2 receptor antagonists on proneurotensin mRNA expression in rat striatum. (1991) (39)
- The distribution and morphology of identified thalamocortical projection neurons and glial cells with reference to the question of interneurons in the ventrolateral nucleus of the rat thalamus (1987) (39)
- New Perspectives on the Neuropathology in Huntington's Disease in the Human Brain and its Relation to Symptom Variation. (2012) (38)
- Localization of calcium-binding proteins and GABA transporter (GAT-1) messenger RNA in the human subthalamic nucleus (1999) (37)
- Proteome map of the human hippocampus (1999) (37)
- A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington's disease human brain (2006) (36)
- Heterogeneous distribution of benzodiazepine receptors in the human striatum: a quantitative autoradiographic study comparing the pattern of receptor labelling with the distribution of acetylcholinesterase staining (1986) (36)
- ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function (2020) (36)
- Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data (2006) (36)
- Identification and characterization of a novel splice variant of the metabotropic glutamate receptor 5 gene in human hippocampus and cerebellum. (2002) (36)
- Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix‐assisted laser desorption/ionization‐imaging mass spectrometry (2016) (35)
- Localization of the somatostatin sst2(a) receptor in human cerebral cortex, hippocampus and cerebellum (1998) (35)
- Molecular investigation of TBP allele length: a SCA17 cellular model and population study (2003) (35)
- Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABAA receptor changes (1999) (35)
- Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity (2015) (35)
- Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington's disease human brain. (2016) (35)
- Induced cerebral hypothermia reduces post-hypoxic loss of phenotypic striatal neurons in preterm fetal sheep (2007) (34)
- No change in progenitor cell proliferation in the hippocampus in Huntington's disease (2011) (34)
- Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridisation study. (1995) (34)
- Identification of a dysfunctional microglial population in human Alzheimer’s disease cortex using novel single-cell histology image analysis (2020) (33)
- Adult Human Glia, Pericytes and Meningeal Fibroblasts Respond Similarly to IFNy but Not to TGFβ1 or M-CSF (2013) (33)
- Interferon-γ blocks signalling through PDGFRβ in human brain pericytes (2016) (33)
- The Basal Ganglia VII (2002) (33)
- Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington’s Disease (2019) (33)
- Immunohistochemical localisation of mGluR7 protein in the rodent and human cerebellar cortex using subtype specific antibodies. (1998) (33)
- Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway (2018) (33)
- Recovery of neurological functions in non-human primate model of Parkinson's disease by transplantation of encapsulated neonatal porcine choroid plexus cells. (2013) (32)
- α-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson’s disease olfactory bulb (2020) (32)
- Association of gephyrin and glycine receptors in the human brainstem and spinal cord: an immunohistochemical analysis (2003) (31)
- A method for generating high-yield enriched neuronal cultures from P19 embryonal carcinoma cells (2012) (29)
- Contrasting Effects of Raclopride and SCH 23390 on the Cellular Content of Preproenkephalin A mRNA in Rat Striatum: A Quantitative Non‐radioactive In Situ Hybridization Study (1992) (29)
- Neurogenesis in the Diseased Adult Human Brain: New Therapeutic Strategies for Neurodegenerative Diseases (2003) (29)
- TBP, a polyglutamine tract containing protein, accumulates in Alzheimer's disease. (2004) (29)
- Spinal cord: cyto and chemoarchitecture (2004) (29)
- Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington's disease brain (2014) (29)
- Prolonged expression of Fos-related antigens, Jun B and TrkB in dopamine-denervated striatal neurons. (1995) (29)
- High throughput quantification of cells with complex morphology in mixed cultures (2007) (28)
- Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography (2011) (28)
- Benzodiazepine receptors in the human cerebellar cortex: a quantitative autoradiographic and pharmacological study demonstrating the predominance of type I receptors (1987) (28)
- Metal concentrations and distributions in the human olfactory bulb in Parkinson’s disease (2017) (28)
- Distribution of gephyrin in the human brain: an immunohistochemical analysis (2003) (27)
- The morphological and chemical characteristics of striatal neurons immunoreactive for the α 1-subunit of the GABAA receptor in the rat (1997) (27)
- Distribution of excitatory and inhibitory amino acid, sigma, monoamine, catecholamine, acetylcholine, opioid, neurotensin, substance P, adenosine and neuropeptide Y receptors in human motor and somatosensory cortex (1991) (27)
- The diversity of GABA(A) receptor subunit distribution in the normal and Huntington's disease human brain. (2015) (27)
- Quantitative immunohistochemical analysis of myeloid cell marker expression in human cortex captures microglia heterogeneity with anatomical context (2020) (26)
- The RAGE receptor and its ligands are highly expressed in astrocytes in a grade‐dependant manner in the striatum and subependymal layer in Huntington's disease (2015) (26)
- Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer's disease. (2020) (26)
- Cerebellar degeneration correlates with motor symptoms in Huntington disease (2019) (26)
- Altered microglia and neurovasculature in the Alzheimer's disease cerebellum (2019) (25)
- Assessing fibrinogen extravasation into Alzheimer's disease brain using high-content screening of brain tissue microarrays (2015) (25)
- Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus (2020) (25)
- Subventricular zone lipidomic architecture loss in Huntington's disease (2018) (25)
- Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington’s disease (2013) (25)
- Insulin and IGF1 modulate turnover of polysialylated neural cell adhesion molecule (PSA–NCAM) in a process involving specific extracellular matrix components (2013) (25)
- Benzodiazepine receptors in the human hippocampal formation: A pharmacological and quantitative autoradiographic study (1988) (24)
- Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer’s Disease (2016) (24)
- Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability. (2000) (24)
- Neurochemical Characterization of PSA-NCAM+ Cells in the Human Brain and Phenotypic Quantification in Alzheimer’s Disease Entorhinal Cortex (2018) (23)
- Decreased Lin7b Expression in Layer 5 Pyramidal Neurons May Contribute to Impaired Corticostriatal Connectivity in Huntington Disease (2010) (23)
- NMDA and kainic acid receptors have a complementary distribution to AMPA receptors in the human cerebellum (1990) (23)
- Aggregate distribution in frontal and motor cortex in Huntington's disease brain (2006) (23)
- Mapping the calcitonin receptor in human brain stem. (2016) (23)
- Localization of the type VI voltage-gated sodium channel protein in human CNS. (1999) (23)
- TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models (2020) (23)
- GABAA receptor subunit and gephyrin protein changes differ in the globus pallidus in Huntington's diseased brain (2003) (22)
- Neurotensin receptors in the human spinal cord: A quantitative autoradiographic study (1989) (22)
- Fragments of HdhQ150 Mutant Huntingtin Form a Soluble Oligomer Pool That Declines with Aggregate Deposition upon Aging (2012) (22)
- First localisation of somatostatin sst(4) receptor protein in selected human brain areas: an immunohistochemical study. (2000) (21)
- The rostral migratory stream and olfactory system: smell, disease and slippery cells. (2009) (21)
- Modelling physiological and pathological conditions to study pericyte biology in brain function and dysfunction (2018) (21)
- Alzheimer's disease markers in the aged sheep (Ovis aries) (2017) (21)
- Interaction of Felbamate with [3H]DCKA-Labeled Strychnine-Insensitive Glycine Receptors in Human Postmortem Brain (1994) (20)
- Adult neurogenesis in mesial temporal lobe epilepsy: a review of recent animal and human studies. (2007) (20)
- Making (anti-) sense out of huntingtin levels in Huntington disease (2015) (20)
- The Acute Effects of Amyloid-Beta1–42 on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus (2020) (20)
- Globus pallidus degeneration and clinicopathological features of Huntington disease (2016) (20)
- Huntington’s Disease and Neural Transplantation: GABAA Receptor Changes in the Basal Ganglia in Huntington’s Disease in the Human Brain and in the Quinolinic Acid Lesioned Rat Model of the Disease Following Fetal Neuron Transplants (1995) (19)
- The unfolded protein response is activated in the olfactory system in Alzheimer’s disease (2020) (19)
- Molecular analysis of the Huntington's disease gene in New Zealand. (1996) (18)
- Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization. (2021) (18)
- Single-cell image analysis reveals a protective role for microglia in glioblastoma (2021) (18)
- Selective neurodegeneration, neuropathology and symptom profiles in Huntington's disease. (2012) (18)
- The role of the human globus pallidus in Huntington's disease (2016) (18)
- Isolation and culture of adult human microglia within mixed glial cultures for functional experimentation and high-content analysis. (2013) (17)
- Proteomic analysis of the human brain in Huntington's Disease indicates pathogenesis by molecular processes linked to other neurodegenerative diseases and to type-2 diabetes. (2013) (17)
- Neuroleptics and striatal neuropeptide gene expression. (1993) (17)
- The Interplay Between Beta-Amyloid 1–42 (Aβ1–42)-Induced Hippocampal Inflammatory Response, p-tau, Vascular Pathology, and Their Synergistic Contributions to Neuronal Death and Behavioral Deficits (2020) (17)
- GABAA RECEPTOR SUBTYPE CHANGES IN THE SUBSTANTIA NIGRA OF THE RAT FOLLOWING QUINOLINATE LESIONS IN THE STRIATUM: A CORRELATIVE IN SITU HYBRIDIZATION AND IMMUNOHISTOCHEMICAL STUDY (1996) (17)
- Autoradiographic visualisation of [3H]DTG binding to σ receptors, [3H]TCP binding sites, and l-[3H]glutamate binding to NMDA receptors in human cerebellum (1991) (16)
- Applying the Bradford Hill Criteria for Causation to Repetitive Head Impacts and Chronic Traumatic Encephalopathy (2022) (16)
- Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS (2019) (16)
- Felbamate increases [3H]glycine binding in rat brain and sections of human postmortem brain. (1998) (16)
- Stroke awareness and knowledge in an urban New Zealand population. (2015) (16)
- Calcium homeostasis in ageing: Studies on the calcium binding protein calbindin D28K (2005) (16)
- The synthesis of a novel Crizotinib heptamethine cyanine dye conjugate that potentiates the cytostatic and cytotoxic effects of Crizotinib in patient-derived glioblastoma cell lines. (2019) (15)
- GABAA Receptors Are Well Preserved in the Hippocampus of Aged Mice (2019) (15)
- Denser brain capillary network with preserved pericytes in Alzheimer's disease (2020) (15)
- Cardiac glycosides target barrier inflammation of the vasculature, meninges and choroid plexus (2021) (15)
- Layer-specific lipid signatures in the human subventricular zone demonstrated by imaging mass spectrometry (2018) (15)
- Studying Human Brain Inflammation in Leptomeningeal and Choroid Plexus Explant Cultures (2016) (14)
- Altered distribution of mGlu2 receptors in β-amyloid-affected brain regions of Alzheimer cases and aged PS2APP mice (2010) (14)
- Endothelial Degeneration of Parkinson's Disease is Related to Alpha-Synuclein Aggregation (2017) (13)
- Isolation and culture of functional adult human neurons from neurosurgical brain specimens (2020) (13)
- C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in New Zealand: a genetic and pathologic study using banked human brain tissue (2017) (13)
- Amyloid-Beta1-42 -Induced Increase in GABAergic Tonic Conductance in Mouse Hippocampal CA1 Pyramidal Cells (2020) (13)
- Amyloid‐beta1–42 induced glutamatergic receptor and transporter expression changes in the mouse hippocampus (2020) (13)
- Indexing-based differential display--studies on post-mortem Alzheimer's brains. (2001) (12)
- The morphological and chemical characteristics of striatal neurons immunoreactive for the alpha1-subunit of the GABA(A) receptor in the rat. (1997) (12)
- Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer’s disease (2022) (12)
- GABA, muscarinic cholinergic, excitatory amino acid, neurotensin and opiate binding sites in the octavolateralis column and cerebellum of the skateRaja nasuta (Pisces: Rajidae) (1994) (12)
- GABAA and GABAB receptor subunit localization on neurochemically identified neurons of the human subthalamic nucleus (2018) (12)
- PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines. (2020) (11)
- Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain. (2013) (11)
- The effect of age and sex on the expression of GABA signaling components in the human hippocampus and entorhinal cortex (2021) (11)
- Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex (2021) (11)
- Current and Possible Future Therapeutic Options for Huntington’s Disease (2022) (11)
- Huntingtin Aggregates in the Olfactory Bulb in Huntington’s Disease (2020) (10)
- Characterisation of PDGF-BB:PDGFRβ signalling pathways in human brain pericytes: evidence of disruption in Alzheimer’s disease (2022) (10)
- Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target (2019) (10)
- Emergence of breath testing as a new non-invasive diagnostic modality for neurodegenerative diseases (2018) (10)
- Differences in Protein Profiles in Schizophrenia Prefrontal Cortex Compared to Other Major Brain Disorders (2007) (10)
- Disrupted vasculature and blood–brain barrier in Huntington disease (2015) (10)
- Regional and cellular distribution of bleomycin hydrolase mRNA in human brain: comparison between Alzheimer's diseased and control brains (2000) (10)
- Soemmerring and the Substantia Nigra (1968) (9)
- Differential Fatty Acid-Binding Protein Expression in Persistent Radial Glia in the Human and Sheep Subventricular Zone (2018) (9)
- High-throughput quantification of Alzheimer’s disease pathological markers in the post-mortem human brain (2009) (9)
- Tikanga in the Laboratory: Engaging Safe Practice (2007) (9)
- GABAA receptor characterization and subunit localization in the human sub ventricular zone (2013) (9)
- Neuroimaging and neuropathology studies of X-linked dystonia parkinsonism (2020) (9)
- Preparation, construction and high-throughput automated analysis of human brain tissue microarrays for neurodegenerative disease drug development (2021) (9)
- Allelic imbalance of tissue-type plasminogen activator (t-PA) gene expression in human brain tissue (2011) (8)
- GABAa Receptor Subunit Subtypes in the Human Putamen and Globus Pallidus in Huntington’s Disease (1996) (8)
- Distribution of GABAA Receptor Subunits in the Human Brain (2010) (8)
- An α5 GABAA Receptor Inverse Agonist, α5IA, Attenuates Amyloid Beta-Induced Neuronal Death in Mouse Hippocampal Cultures (2020) (8)
- Chemical neuroanatomy of the substantia nigra in the ovine brain (2019) (7)
- An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington’s disease caudate nucleus (2021) (7)
- Cortico-Basal Ganglia Interactions in Huntington’s Disease (2016) (7)
- The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers. (2017) (7)
- The localization of inhibitory neurotransmitter receptors on dopaminergic neurons of the human substantia nigra. (2009) (7)
- Use of [3H]5,7 dichlorokynurenic acid to identify strychnine-insensitive glycine receptors in human postmortem brain (1994) (7)
- Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer’s and Parkinson’s disease patients (2022) (6)
- Receptors in the Human Spinal Cord (1991) (6)
- Vascular Remodelling is Impaired in Parkinson Disease (2017) (6)
- Insulin promotes cell migration by regulating PSA‐NCAM (2017) (5)
- fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer’s disease using an automated quantitative analysis workflow (2020) (5)
- Normal aging, motor neurone disease, and Alzheimer’s disease are characterized by cortical changes in inflammatory cytokines (2021) (5)
- Neuroprotective Effect of Caffeine in Alzheimer’s Disease (2022) (5)
- Variable Susceptibility to Neurotoxicity of Systemic 3-Nitropropionic Acid (2000) (4)
- A role for human brain pericytes in neuroinflammation (2014) (4)
- Therapeutic potential of alpha 5 subunit containing GABAA receptors in Alzheimer’s disease (2021) (4)
- Microglia Mediate Early Corticostriatal Synapse Loss and Cognitive Dysfunction in Huntington’s Disease Through Complement-Dependent Mechanisms (2021) (4)
- Excitatory amino acids, NMDA and sigma receptors: A role in schizophrenia? (1991) (4)
- Huntington's disease: Understanding a mutation (2011) (4)
- Neurotransmitter Receptors in the Basal Ganglia (2010) (4)
- Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism (2021) (4)
- No symphony without bassoon and piccolo: changes in synaptic active zone proteins in Huntington’s disease (2020) (4)
- Comparison of Huntington's disease CAG Repeat Length Stability in Human Motor Cortex and Cingulate Gyrus. (2016) (4)
- Felbamate: interaction with glycine receptors in human cerebral cortex. (1994) (4)
- Beta-Amyloid (Aβ1-42) Increases the Expression of NKCC1 in the Mouse Hippocampus (2022) (4)
- EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer’s Disease (2021) (4)
- Stem cells and neurodegenerative diseases. (2001) (4)
- RNA Quality in Post-mortem Human Brain Tissue Is Affected by Alzheimer’s Disease (2021) (4)
- Huntington’s Disease and Neural Transplantation (1996) (3)
- UREA CYCLE ENZYMES AND PEPTIDYLARGININE DEIMINASE IN ALZHEIMER’S SUPERIOR FRONTAL GYRUS (2016) (3)
- Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress (2022) (3)
- The autocrine regulation of insulin-like growth factor-1 in human brain of Alzheimer’s disease (2021) (3)
- Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines. (2021) (3)
- Stereological Methods to Quantify Cell Loss in the Huntington's Disease Human Brain. (2018) (3)
- Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus (2022) (3)
- Regional protein expression in human Alzheimer’s brain correlates with disease severity (2018) (3)
- The Termination of Striatonigral Fibres on Nigrotectal Neurons in the Rat — A Preliminary Report (1984) (3)
- Arginine decarboxylase and agmatinase immunoreactivity in Alzheimer’s superior frontal gyrus (2015) (3)
- The effects of amyloid-beta on hippocampal glutamatergic receptor and transporter expression (2020) (3)
- C9ORF72 and UBQLN2 are genetic causes of ALS in New Zealand (2016) (3)
- Identifying neural progenitor cells in the adult human brain. (2013) (2)
- The amyotrophic lateral sclerosis-linked protein TDP-43 regulates interleukin-6 cytokine production by human brain pericytes (2022) (2)
- GABA A RECEPTOR SUBUNIT SUBTYPES IN THE HUMAN PUTAMEN AND GLOBUS PALLIDUS IN HUNTINGTON'S DISEASE An in Situ Hybridization Study (1996) (2)
- EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review (2022) (2)
- Erratum to: A role for human brain pericytes in neuroinflammation (2015) (2)
- Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease (2018) (2)
- Effect of post-mortem delay on N-terminal huntingtin protein fragments in human control and Huntington disease brain lysates (2017) (2)
- B07 Analysis of huntingtin protein fragments in post mortem human Huntington's disease brain tissue (2012) (2)
- TBK1 regulates autophagic clearance of soluble mutant huntingtin and inhibits aggregation/toxicity in different models of Huntington’s disease (2019) (2)
- Epigenetic Regulation of Tissue-Type Plasminogen Activator in Human Brain Tissue and Brain-Derived Cells (2016) (2)
- The morphology of human neuroblastoma cell grafts in the kainic acid-lesioned basal ganglia of the rat (1995) (2)
- Inconsistencies in histone acetylation patterns among different HD model systems and HD post-mortem brains (2020) (2)
- Cation-Chloride Cotransporters KCC2 and NKCC1 as Therapeutic Targets in Neurological and Neuropsychiatric Disorders (2023) (1)
- N-terminal mutant huntingtin deposition correlates with CAG repeat length and symptom onset, but not neuronal loss in Huntington's disease (2022) (1)
- Cytoarchitectural, dendroarchitectural and myeloarchitectural organization (1990) (1)
- Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue (2022) (1)
- Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS (2021) (1)
- P04.23 Pericytes contribute to tumour immune system evasion in glioblastoma multiforme through the under-expression of ICAM-1, VCAM-1 and MCP-1. (2018) (1)
- The Cellular Localisation of GABAA and Glycine Receptors in the Human Basal Ganglia (2009) (1)
- The Neuropathology of Huntington’s Disease in the Human Brain (2014) (1)
- Characterisation of a transgenic ovine model of Huntington’s disease (2011) (1)
- Metal concentrations and distributions in the human olfactory bulb in Parkinson’s disease (2017) (1)
- A Multi-Omic Huntington’s Disease Transgenic Sheep-Model Database for Investigating Disease Pathogenesis (2021) (1)
- Human pericytes degrade diverse α-synuclein aggregates (2022) (1)
- Antagonistic roles of canonical and alternative RPA in tandem CAG repeat diseases (2022) (1)
- Bulk handling racks for free-floating serial sections, especially suitable for nauta staining. (1968) (1)
- Identifying Neural Progenitor Cells in the Adult Human Brain. (2021) (1)
- Modelling physiological and pathological conditions to study pericyte biology in brain function and dysfunction (2018) (1)
- Benzodiazepine Receptors in the Striatum of the Human Brain (1987) (1)
- 29 Adult Human Neurogenesis: A Response to Cell Loss and New Circuitry Requirements? (2008) (1)
- Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer’s Disease? (2023) (1)
- DECREASED MESSENGER RNA IN THE NEURONAL NITRIC OXIDE SYNTHASE RNA AND SOMATOSTATIN MESSENGER STRIATUM OF HUNTINGTON'S DISEASE (1996) (1)
- The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients (2017) (0)
- PSA-NCAM Regulatory Gene Expression Changes in the Alzheimer's Disease Entorhinal Cortex Revealed with Multiplexed in situ Hybridization. (2023) (0)
- My wonderful, exciting, and serendipitous journey in brain research, culminating in the establishment of the Centre for Brain Research — A dream come true! (2021) (0)
- Human pericytes degrade α-synuclein aggregates in a strain-dependent manner (2022) (0)
- No symphony without bassoon and piccolo: changes in synaptic active zone proteins in Huntington’s disease (2020) (0)
- M-CSF increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia (2013) (0)
- B4 Detection of the aberrantly spliced exon 1 – intron 1 htt mRNA in HD patient post mortem brain tissue and fibroblast lines (2016) (0)
- Collagen deposition in an experimental model of brain damage and brain sections from patients with Alzheimers disease (2000) (0)
- SH-SY5Y cells and primary pericytes exchange α-Synuclein through tunnelling nanotubes (2016) (0)
- Unique and shared inflammatory profiles of human brain endothelia and pericytes (2018) (0)
- PU.1 regulates Alzheimer’s disease-associated genes in primary human microglia (2018) (0)
- Erratum to: A role for human brain pericytes in neuroinflammation (2015) (0)
- Presence of mutant huntingtin aggregates in the anterior olfactory nucleus of the human Huntington's disease olfactory bulb (2018) (0)
- Regional specificity of transcriptional changes in early grade Huntington's disease brain (2005) (0)
- Development of a novel 13C-labelled methionine breath test protocol for potential assessment of hepatic mitochondrial function in sheep using isotope-ratio mass spectrometry (2019) (0)
- Identification of a dysfunctional microglial population in human Alzheimer’s disease cortex using novel single-cell histology image analysis (2020) (0)
- α-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson’s disease olfactory bulb (2020) (0)
- Cells isolated from adult human brain. Are they fibroblasts, neural stem cells or both? (2009) (0)
- The unfolded protein response is activated in the olfactory system in Alzheimer’s disease (2020) (0)
- Quantification of non-neuronal cells containing intracellular α-synuclein in the human Parkinson’s disease olfactory bulb (2018) (0)
- A05 Cellular and regional gene expression changes in human Huntington's disease cortex correlate with symptom profiles (2010) (0)
- Immunohistochemical Localisation of Tata-Binding Protein in Huntington’s Disease Cortex (2002) (0)
- O.084 Correlation of the genetics, symptomatology, pathology and stem cell proliferation in Huntington's disease (2009) (0)
- The Human Globus Pallidus In Huntington’s Disease: Characterization of volumetric changes, pallidal neuron loss and cell morphology in association with pathological grade and symptom-type (2013) (0)
- Microrna regulation of human brain pericytes (2015) (0)
- mGluR1α expression in the hippocampus, subiculum, entorhinal cortex and superior temporal gyrus in Alzheimer’s disease (2022) (0)
- The tracts, cytoarchitecture, and neurochemistry of the spinal cord (2022) (0)
- Abstracts from HSG 2017 (2017) (0)
- Decreases in the multidrug transporter, P-glycoprotein, in the brain vasculature of subjects with Alzheimer’s disease (2008) (0)
- Hippocampal protein aggregation signatures fully distinguish pathogenic and wildtype UBQLN2 in amyotrophic lateral sclerosis (2022) (0)
- 250. Protection Against Huntington's Diease Progression: AAV-Mediated Delivery of Biotherapeutics (2006) (0)
- Studying Human Brain Inflammation in Leptomeningeal and Choroid Plexus Explant Cultures (2015) (0)
- Studies on the projections of the superior cerebellar peduncle and the rubrothalamic and nigrothalamic projections in the rat, and their relevance to the homologies of the anterior parts of the ventral nucleus of the thalamus in the mammalian brain. (1975) (0)
- Distinct characteristics of microglia from neurogenic and non-neurogenic regions of the human brain in patients with Mesial Temporal Lobe Epilepsy (2022) (0)
- Dynamics of somatic CAG instability in Huntington's disease. (2005) (0)
- Interferon-γ blocks signalling through PDGFRβ in human brain pericytes (2016) (0)
- Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease (2018) (0)
- Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease (2018) (0)
- 451. AAV-BDNF Augments Neurogenesis in Both the Normal Adult Rat Brain and the Quinolinic Acid Lesion Model of Huntington's Disease (2006) (0)
- Recycling old drugs: cardiac glycosides as therapeutics to target barrier inflammation of the vasculature, meninges and choroid plexus (2020) (0)
- AAV-BDNF augments neurogenesis in both the normal adult rat brain and the quinolinic acid lesion model of Huntington's disease (2006) (0)
- Persistent radial glial cells in the adult human and sheep SVZ differentially express Fatty Acid Binding proteins (FABPs) (2014) (0)
- TMIC-21. THE POTENTIAL CONTRIBUTION OF PERICYTES TO GLIOBLASTOMA MULTIFORME TUMOUR MICRO-ENVIRONMENT IMMUNOSUPPRESSION VIA DAMPENED EXPRESSION OF ICAM-1, VCAM-1 AND MCP-1 (2018) (0)
- Layer-specific lipid signatures in the human subventricular zone demonstrated by imaging mass spectrometry (2018) (0)
- Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia (2023) (0)
- Erratum to: Studying Human Brain Inflammation in Leptomeningeal and Choroid Plexus Explant Cultures (2016) (0)
- Phagocytosis by human brain pericytes: implications for Alzheimer’s disease (2016) (0)
- P2-001 MELATONIN SUPPLEMENT ONLYAT SPECIFIC TIMING RESCUES THE PATHOLOGYAND MEMORY DEFICITS IN TG2576 MICE VIA TARGETING GSK-3 (2013) (0)
- Sex- and age-related changes in GABA signaling components in the human cortex (2019) (0)
- Chapter 8 – Huntington Disease (2017) (0)
- Dual in situ hybridization and immunohistochemistry for quantitative analysis of house-keeping gene changes in normal and Alzheimer’s disease brain tissue (2019) (0)
- TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function (2016) (0)
- DARPP‐32 cells and neuropil define striosomal system and isolated matrix cells in human striatum (2023) (0)
- Making (anti-) sense out of huntingtin levels in Huntington disease (2014) (0)
- Copper, zinc, iron, and manganese in the healthy and Parkinson’s disease human brain (2015) (0)
- Altered arginine metabolism in the Alzheimer's hippocampus (2013) (0)
- Cost of brain disorders (1992) (0)
- Characterization of volumetric growth of intracranial meningiomas in Māori and Pasifika populations in New Zealand (2022) (0)
- A missense mutation of human Gephyrin (GPHN) is associated with Hyperekplexia and transcript isoform analysis re-defines the genomic structure of GPHN. (2001) (0)
- Cardiac glycosides target barrier inflammation of the vasculature, meninges and choroid plexus (2021) (0)
- Cover Image, Volume 531, Issue 8 (2023) (0)
- The Immunohistochemical Localisation of GABA A Receptor Subunits in the Human Striatum (2002) (0)
- iGluR expression in the hippocampal formation, entorhinal cortex, and superior temporal gyrus in Alzheimer’s disease (2022) (0)
- Resource Cell-Type-Specific Gene E xpression Profiling in Adult Mouse Brain Reveals Normal and Disease-State Signatures Graphical (2019) (0)
- Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug‐carrier molecule for the treatment of glioblastoma (2022) (0)
- P10.03 Immunological differences between patient-matched normal-derived and GBM-derived pericytes (2019) (0)
- Differential patterns of neurodegeneration in the human globus pallidus in Huntington’s disease (2014) (0)
- Erratum to: Studying Human Brain Inflammation in Leptomeningeal and Choroid Plexus Explant Cultures (2016) (0)
- Huntington’s disease: It’s about whanau. (2012) (0)
- Blood-spinal cord barrier leakage is not caused by neurodegeneration in amyotrophic lateral sclerosis (2019) (0)
- Globus pallidus neurodegeneration links to symptom heterogeneity in Huntington’s disease (2015) (0)
- Poster Presentation (2022) (0)
- Cellular Localisation of the GabaB R1 Subunit in the Human Basal Ganglia (2002) (0)
- Differential exon usage and cryptic exon profiles of TDP-43 loss of function in amyotrophic lateral sclerosis brain tissue (2023) (0)
- Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer’s disease (2022) (0)
- Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain (2023) (0)
- Non-neuronal cells enable transmission of α-synuclein in Parkinson’s disease (2018) (0)
- Neurogenesis in the Basal Ganglia in Huntington’s Disease in the Human Brain and in an Animal Model (2005) (0)
This paper list is powered by the following services:
Other Resources About Richard Faull
What Schools Are Affiliated With Richard Faull?
Richard Faull is affiliated with the following schools:
